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Outcomes of single organism peritonitis in peritoneal dialysis: Gram
negatives versus gram positives in the Network 9 Peritonitis Study. The
use of the "peritonitis rate" in the management of patients undergoing
peritoneal dialysis is assuming importance in comparing the prowess of
facilities, care givers and new innovations. For this to be a meaningful
outcome measure, the type of infection (causative pathogen) must have
less clinical significance than the number of infections during a time
interval. The natural history of Staphylococcus aureus, pseudomonas, and
fungal peritonitis would not support that the outcome of an episode of
peritonitis is independent of the causative pathogen. Could this concern
be extended to other more frequently occurring pathogens? To address
this, the Network 9 Peritonitis Study identified 530 episodes of single
organism peritonitis caused by a gram positive organism and 136 episodes
caused by a single non-pseudomonal gram negative (NPGN) pathogen.
Coincidental soft tissue infections (exit site or tunnel) occurred equally in
both groups. Outcomes of peritonitis were analyzed by organism classifi-
cation and by presence or absence of a soft tissue infection. NPGN
peritonitis was associated with significantly more frequent catheter loss,
hospitalization, and technique failure and was less likely to resolve
regardless of the presence or absence of a soft tissue infection. Hospital-
ization and death tended to occur more frequently with enterococcal
peritonitis than with other gram positive peritonitis. The outcomes in the
NPGN peritonitis group were significantly worse (resolution, catheter loss,
hospitalization, technique failure) compared to coagulase negative staph-
ylococcal or S. aureus peritonitis, regardless of the presence or absence of
a coincidental soft tissue infection. Furthermore, for the first time, the
poor outcomes of gram negative peritonitis are shown to be independent
of pseudomonas or polymicrobial involvement or soft tissue infections.
The gram negative organism appears to be the important factor. In
addition, the outcome of peritonitis caused by S. aureus is worse than that
of other staphylococci. Thus, it is clear that all peritonitis episodes cannot
be considered equivalent in terms of outcome. The concept of peritonitis
rate is only meaningful when specific organisms are considered.
Infectious complications are the major cause of morbidity and
technique failure in a peritoneal dialysis program [1—3]. Peritoni-
tis rates are being utilized as an outcome measure, in particular
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for comparing facilities or technical innovations. For "peritonitis
rate" to be a meaningful measure, it is presumed that each
episode of peritonitis will have reasonably equivalent short- and
long-term outcomes. This premise does not appear to be valid.
Peritonitis caused by certain pathogens such as pseudomonads
(xanthomonads) and fungi is associated with increased catheter
loss and transfer to hemodialysis [4—8], while peritonitis due to
Staphylococcus epidennidis has a higher resolution rate than
peritonitis caused by other pathogens [9—11]. Polymicrobial peri-
tonitis is thought to originate from a bowel leak [12—14]. Thus,
one would expect a worse outcome from a bowel leak etiology
rather than from an infection caused by touch contamination. The
source of gram negative organisms in peritoneal dialysis associ-
ated peritonitis has been speculated to be either a gastrointestinal
or skin source [5, 11, 14]. Pseudomonas and polymicobes can bias
an outcomes analysis of gram negative peritonitis. For example, it
is uncertain if the outcomes of peritonitis caused by a single
non-pseudomonal gram negative (NPGN) organism are clearly
different than those caused by various gram positive organisms.
The Tn-State Renal (Network 9) of the Health Care Finance
Administration End-Stage Renal Disease Networks performed a
year long prospective study of all peritonitis episodes. Of interest
are the differences between infections with single gram negative
or gram positive organisms and among S. aureus and other
staphylococci. We hypothesized that: (1) there is a difference in
outcomes between NPGN peritonitis and gram positive peritoni-
tis; (2) there is a difference in demographics between patients
experiencing their first episode of peritonitis with a gram negative
versus a gram positive organism; (3) there are outcome differ-
ences between gram negative and gram positive episodes inde-
pendent of pseudomonal or polymicrobial involvement or soft
tissue infections (STI, exit site and catheter tunnel tract); (4) there
are outcome differences among S. aureus peritonitis, other staph-
ylococci and other gram positive organisms; (5) the outcome
difference among S. aureus peritonitis and other staphylococci is
independent of STIs.
METHODS
Network 9 (Indiana, Ohio, Kentucky, ESRD Tn-State Renal
Network, HCFA contract #500-91-0014) prospectively evaluated
all 1930 patients undergoing peritoneal dialysis (PD) at the 68
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a Non-pseudomonal gram negative
h In later tables these organisms are
staphylococci (CNS).
Table 1. Organisms cultured from peritoneal dialysate
Gram positive N NPGN N
1) Staphylococcus aureus
2) Staphylococcus epidermis5
3) Other Staphylococci5
4) Enterococcus
5) Other gram positive
Total
149
220
22
27
112
530
1) E. coli
2) Klebsiella
3) Enterobacter
4) Serratia
5) Acinetobacter
6) Proteus
7) Other NPGN's
19
21
19
9
10
5
53
Total 136
centers in this Network for one year starting on 1/1/91. For each
PD patient in their unit every dialysis facility completed a detailed
patient identification questionnaire which included demographic
data. An additional "event" questionnaire form was completed for
each peritonitis episode. This included information about signs,
symptoms, organisms cultured, treatment, and outcome. The
event forms were sent to the Network 9 office in Indianapolis
where the data were entered into the computerized data base.
The nature of the data collected as well as data validation was
performed by several techniques and described in detail elsewhere
[4, 9]. Dialysis facilities had incentives to participate accurately in
the study, in particular because they would receive facility specific
information for their quality assurance programs. Validation
included analyses of reported cases versus those expected based
on known established Network 9 rates during the first months of
the study. Discrepancies were identified and these facilities were
telephoned and visited as necessary to insure compliance with
reporting. The total number of estimated missed peritonitis
episodes represents from 6% to 8% of the total number of
reported peritonitis episodes.
The Network 9 Peritonitis and Catheter Survival Study defined
resolution of peritonitis as the clearing of peritoneal dialysate
effluent on visual inspection after antibiotic therapy. The printed
study instructions specifically mandated that "a separate infection
event is defined as peritonitis due to a different organism or an
infection from the same organism after a 14 day infection-free
interval without antibiotics." All cases presented in this commu-
nication fit this definition. By this definition reinfections would be
included in this analysis, except for the demographic comparison,
which were first episodes only (see below). Further definitions
(such as soft tissue infection, bowel perforation) were left to the
facilities. Non-resolution was arbitrarily defined as the lack of
clearing after up to three courses of antibiotic therapy. A course
of antibiotics was defined as the addition of any new (different)
antibiotic or different combination of antibiotics, without a spe-
cific duration of therapy. If the peritonitis did not resolve with
three courses of antibiotics, it was classified as non-resolution.
The additional outcome parameters catheter removal, transfer to
hemodialysis, and death were captured on the event forms totally
independent of resolution of peritonitis with antibiotic therapy.
Thus, it was possible for a peritonitis episode to be reported that
had not "resolved," but in which the catheter had not been
removed or the patient had not been transferred to hemodialysis
or had not died. There were 59 such episodes in the gram positive
group (11.1%) and 17 episodes in the NPGN group (12.5%).
These episodes were included in the catheter not removed, no
transfer to hemodialysis, and no death groups during outcome
analysis. The outcomes catheter removal, resolution, transfer to
hemodialysis (HD), and death were not mutually exclusive so that
a patient could have resolved his/her infection and have trans-
ferred to hemodialysis. A soft tissue infection (STI) is an exit site
or catheter tunnel tract infection defined by the individual facili-
ties. As detected in the questionnaire, a STI was a coincidental
infection to the peritonitis event and did not have to be caused by
the same organism as that causing peritonitis, nor was the
pathogen from the STI necessarily recorded. The STI was merely
present or absent on the event form.
This analysis was confined to patients 20 years of age or older
on 1/1/91 with a positive peritoneal effluent culture with a single
pathogen isolated as either a gram positive or a NPGN organism.
lumped as coagulase negative
Episodes of culture negative peritonitis were excluded due to the
uncertainty of the cause and the Network 9 experience with
culture negative peritonitis has been described in detail elsewhere
[15]. If patients experienced an episode of gram positive perito-
nitis early in the year followed later in the year by NPGN
peritonitis, it would result in the counting of the patient in each
group. If the patient had two episodes of gram positive or NPGN
peritonitis in a year (including reinfections), each episode repre-
sented a case. Ninety-five patients had two episodes and 39
patients had three or more episodes of peritonitis described in this
report. Relapses were addressed in the 14 day instructions de-
scribed above and were not counted as separate episodes. An
additional demographic analysis was performed on patients with
only their first clinical diagnosis of peritonitis occurring during the
1991 study period. This was done to remove the possible con-
founding effect of previous episodes of peritonitis [9]. An analysis
of antibiotic therapy was complicated by the absence of a uniform
treatment protocol. Therefore, we herein report only the length
and route of therapy. The initial antibiotics utilized and outcomes
related to specific antibiotics were the subject of a previous report
[16]. Episodes of pseudomonal peritonitis are described elsewhere
[4] and reiterated in the discussion below. The method of culture
of peritoneal fluid and the antibiotic regimens used were deter-
mined by each facility. Statistical analysis was performed by chi
square using SPSS, Fischer's exact test when cell size was small,
and the t-test. Statistical significance was defined as a P value <
0.05. Data are described with a mean one so.
RESULTS
There were 530 episodes of peritonitis caused by a single gram
positive organism and 136 episodes of peritonitis caused by a
single NPGN organism. One hundred thirty-four patients experi-
enced 322 of the episodes and 344 patients experienced only one
episode of peritonitis during 1991. The various organisms respon-
sible are shown in Table 1. S. aureus and S. epidermidis were the
etiologic agent in 69.6% of the episodes of gram positive perito-
nitis. During 1991, enterococcus comprised only 5.1% of the
episodes of single organism gram positive peritonitis. E. coli,
klebsiella, and enterobacter accounted for 43.4% of the single
NPGN peritonitis episodes. Fever (P < 0.01), nausea/vomiting
(P < 0.02), and abdominal pain (P < 0.04) occurred more
frequently in NPGN and S. aureus peritonitis than in peritonitis
caused by coagulase negative staphylococci. There was a sugges-
tion of an increased incidence of bowel perforation in the NPGN
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Table 2. Outcomes
CNSC
N = 242
S. aureus
N = 149
NPGN'
N = 136
P V
CNS-
NPGN
alue
S. aureus-
NPGN
Resolved 83.8% 75.8% 58.8% 0.01 0.03
Catheter removed 4.6% 18.1% 30.0% 0.001 0.02
Hospitalization 17.9% 29.5% 44.1% 0.001 0.02
Transfer to HD 1.3% 8.7% 14.0% 0.001 0.2
Death 0.8% 3.4% 3.7% 0.1 1.0
a Coagulase negative staphylococcib Non-pseudomonal gram negatives
Table 3. Outcomes in absence of exit site or tunnel infection
CNSC
N 230
S. aureus
N = 104
NPGNb
N = 114
P v
CNS-
NPGN
alue
S. aureus-
NPGN
Resolved 84.6% 82.7% 63.2% 0.001 0.002
Catheter removed 3.1% 12.5% 23.7% 0.001 0.04
Hospitalization 17.5% 30.1% 43.0% 0.001 0.05
Transfer to HD 0.8% 2.9% 9.6% 0.002 0.06
Coagulase negative staphylococcibNon-pseudomonal gram negatives
group compared to the gram positive group (NPGN = 3/136, vs.
gram positive = 2/530, P = 0.06).
The outcomes for the episodes of staphylococcal and NPGN
peritonitis are shown in Table 2. The outcomes are worst for
NPGN, intermediate for S. aureus and best for CNS in all
categories listed.
There was no difference in the incidence of STIs coincident with
the episode of peritonitis between the two groups (NPGN, 16.2%;
all gram positive, 14.2%). Outcomes of peritonitis episodes in the
staphylococcal and NPGN groups were analyzed in the presence
and absence of STI (Tables 3 and 4). The outcomes in the NPGN
peritonitis group were significantly worse (resolution of peritoni-
tis, loss of catheter, hospitalization, and transfer to HD) com-
pared to staphylococcal peritonitis whether a soft tissue infection
was present or not. There was no difference in mortality between
the groups in the presence or absence of a STI (data not shown).
Episodes of NPGN peritonitis that occurred with a coincidental
STI had a significantly lower rate of resolution with up to three
courses of antibiotics (NPGN with STI, 36.4% vs. 63.2% without
STI, P = 0.031), had a higher rate of catheter removal (STI,
63.7% vs. 23.7% without STI, P < 0.001), and a higher rate of
transferring to hemodialysis (STI, 36.4% vs. 9.6% without STI,
P = 0.003). There was no difference in the rate of hospitalization
or deaths between NPGN peritonitis episodes with or without a
coincidental STI. The outcome data for staphylococcal peritonitis
episodes with or without a concomitant STI revealed a similar
pattern to those in the NPGN group. A significant decrease in
resolution (STI, 64% vs. 81.7% without STI, P = 0.001), an
increase in catheter removal (STI, 30.7% vs. 6.4% without STI,
P < 0.0001), and an increased transfer to hemodialysis (STI, 16%
vs. 1.5% without STI, P < 0.0001) was noted in staphylococcal
peritonitis episodes that occurred with a STI. There was no
difference in hospitalization rates or deaths in the staphylococcal
Table 4. Outcomes in presence of exit site or tunnel infection
CNs
N = 12
S. aureus
N = 45
NPGNb
N = 22
P v
CNS-
NPGN
alue
S.
NPGN
Resolved 66.7% 60% 36.4% 0.15 0.12
Catheter removed 33.3% 31.1% 63.7% 0.15 0.02
Hospitalization 25% 26.7% 50.0% 0.27 0.10
Transfer to HD 8.3% 22.2% 36.4% 0.11 0.25
a Coagulase negative staphylococcibNon-pseudomonal gram negatives
Table 5. Demographics of patients with their first episode of peritonitis
All gram positiveN = 106
NPGNC
N = 32 Pvalue
Age  60 38.7% 39.1% NS
Male 50.0% 50.0% NS
Diabetes 41.5% 28.1% NS
Afro-American 18.8% 25.8% NS
2 infect in l99l' 33.0% 15.6% 0.075
Steroidsa 23.9% 13.6% NS
a Non-pseudomonal gram negativesbGreater than or equal to 2 episodes of peritonitis in 1991
C Currently receiving steroids or have received them in the past
peritonitis group, regardless of the presence or absence of a
coincidental STI.
During 1991 there were 106 patients who had a first episode of
peritonitis with a single gram positive organism and 32 patients
that had a first episode of peritonitis with a single NPGN
organism (Table 5). There were no significant demographic
differences between the two groups, but there was a trend towards
an increase in the subsequent number of peritonitis episodes later
in the year in the gram positive group.
Episodes of NPGN peritonitis were treated for significantly
longer times with intraperitoneal antibiotics: NPGN episodes
were 9.1 8.5 days (mean SD) versus 7.1 6.7 days for all gram
positive episodes (P = 0.004). NPGN peritonitis was also treated
for longer periods of time by the oral route: NPGN episodes were
2.7 5.9 days versus 1.7 4.7 days for all gram positive
peritonitis (P = 0.044). No significant difference in the length of
i.v. drug therapy was noted (NPGN 0.6 3.1 day vs. 1.7 6.9 for
all gram positive peritonitis, P = 0.07).
The 27 reported cases of enterococcal peritonitis were com-
pared to all other forms of gram positive peritonitis and did not
differ in such complications or outcomes as incidence of concom-
itant STI, catheter removal, resolution of peritonitis, or transfer to
hemodialysis. There were suggestions of an increase in mortality
and hospitalizations in the enterococcal group (death, enterococ-
cus 7.4% vs. other gram positive, 2.2%, P = 0.087; hospitalization
for enterococcus, 40.7% vs. other gram positive, 24.4%, P =
0.057).
When S. aureus was compared to all other episodes of gram
positive peritonitis, there were significant increases in catheter
removal and transfer to hemodialysis (catheter removal for S.
aureus was 18.12% vs. other gram positive, 6.6%, P < 0.0001;
transfer to hemodialysis, S. aureus 8.7% vs. other gram positive,
1.5%, P < 0.0001). There were no significant differences in the
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Table 6. Outcomes S. aureus vs. coagulase negative staphylococcus
S. aureus
N 149
CNS
N = 242 P value
Resolved 75.8% 83.8% 0.054
Catheter removed 18.1% 4.6% <0.0001
Hospitalization 29.5% 17.9% 0.007
Transfer to HD 8.7% 1.3% 0.003
Death 3.4% 0.8% 0.068
a Coagulase negative staphylococcus
rate of resolution, hospitalization or death. Thirty percent of the
episodes of S. aureus peritonitis occurred concomitantly with a
STI as compared to 6.0% of the other episodes gram positive
peritonitis (P < 0.0001).
Compared to all coagulase negative staphylococci (CNS) peri-
tonitis episodes, S. aureus peritonitis resulted in a significantly
higher rate of catheter removal, hospitalization and transfer to
hemodialysis (Table 6). There was a suggestion of a decrease in
the rate of resolution of peritonitis and an increase in deaths in
the S. aureus group. As noted above 30% of the S. aureus
peritonitis episodes had a concomitant soft tissue infection com-
pared to only 5% for CNS peritonitis (P < 0.000 1).
To determine if the differences in peritonitis episode outcomes
between S. aureus and CNS was related to coincidental STIs, we
compared the outcomes of peritonitis episodes between these 2
groups in the absence and presence of concomitant STIs (Table
7). Even in the absence of STI, S. aureus peritonitis had a
significantly higher rate of catheter removal and hospitalization
compared to CNS peritonitis. There was no difference in the rate
of resolution, transfer to hemodialysis, or death. Even in the
presence of a coincidental STI, there were no differences between
the S. aureus and CNS groups in the following outcome parame-
ters: resolution, catheter removal, hospitalization, transfer to
hemodialysis, or death. For some parameters this may simply be a
reflection of sample size.
DISCUSSION
The Network 9 Peritonitis and Catheter Survival Study data
have been analyzed to examine the differences in the demograph-
ics and outcomes in single organism NPGN peritonitis compared
to gram positive peritonitis episodes, particularly those caused by
S. aureus and CNS. The first episode of peritonitis was used for
the demographic analysis to minimize the effect of prior perito-
nitis, a known confounding risk factor [9]. Although the event
questionnaires were updated during the course of the infection,
the nature of this study is essentially retrospective. This could
influence some aspects of severity measures such as frequency of
hospitalization and catheter removal. Since the centers had
incentives to carefully describe the events, we trust that the data
are accurate. While there were no differences in the patient
demographics between the NPGN and gram positive peritonitis
groups who were experiencing their first episode of peritonitis, the
outcomes of the peritonitis episodes was more frequently worse in
the NPGN group. Thus, by excluding pseudomonas, polymicrobial
contamination, and the role of soft tissue infections, it is clear that
gram negative peritonitis results in worse outcomes than perito-
nitis caused by S. aureus or CNS.
Similar to the findings of Tranaeus, Heimburger and Lindholm
Table 7. Outcomes in the absence of exit site or tunnel infection
S. aureus
N = 104
CNS
N = 230 P value
Resolved 82.7% 84.6% NS
Catheter removed 12.5% 3.1% .002
Hospitalization 30.1% 17.5% .015
Transfer to HD 2.9% 0.8% .18
Death 2.9% 0.8% .18
a Coagulase negative staphylococcus
[11], Network 9 patients with episodes of NPGN and S. aureus
peritonitis had more severe clinical signs and symptoms than
those with other gram positive peritonitis. However, the clinical
utility of symptom severity is limited.
There are minimal data that directly compare the outcomes of
single organism NPGN peritonitis to that of gram positive peri-
tonitis [16]. The present results show that compared to peritonitis
caused by S. aureus or CNS, there are significantly worse out-
comes with NPGN peritonitis (catheter removal, resolution, hos-
pitalization, transfer to HD) despite longer antibiotic treatment
duration by the intraperitoneal and oral routes. Because STIs
were coincident to peritonitis, locally defined, and the causative
pathogens not recorded, STI data should be cautiously inter-
preted. Nonetheless, the worse outcomes with NPGN peritonitis
could not be attributed to an increased incidence of soft tissue
infections. When peritonitis episodes without STI were compared,
the outcomes (resolution, catheter removal, hospitalization, and
transfer to HD) in the NPGN group were still significantly worse.
Episodes of NPGN peritonitis with a coincidental STI had
significantly worse resolution rates, higher rates of catheter re-
moval, and change to hemodialysis when compared to gram
positive peritonitis with a coincidental STI. Therefore, episodes of
NPGN peritonitis have worse outcomes compared to gram posi-
tive peritonitis independent of a coincidental soft tissue infection.
Enterococcal peritonitis tended to result in an increase of fre-
quency of hospitalization and deaths when compared to other
gram positive peritonitis.
In order to examine the outcomes of other gram negative
infections, pseudomonal peritonitis was excluded from the
present analysis but is described in detail elsewhere [4]. Essen-
tially, episodes of pseudomonal peritonitis were associated with
significantly lower rates of resolution (pseudomonas 32.25% vs.
58.8% NPGN, P < 0.01) and significantly higher rates of catheter
loss (pseudomonas 61.3% vs. 30% other NPGN, P < 0.002).
There were no significant differences in the rate of transfering to
HD (pseudomonas 25.8% vs. 14% for NPGN) or death (pseudo-
monas 6.5% vs. 3.7% NPGN) between these two groups. The poor
outcomes with pseudomonal infections is attributed to the viru-
lence of the organism. The present study expands the comparison
of different outcomes by causative pathogen.
The reason for the poor outcomes with NPGN peritonitis is not
clear. One possibility is that early in the course of therapy the
patients with gram negative peritonitis were not treated with
antibiotics to cover gram negative organisms. In a previous
Network 9 report, 12 of 73 patients with gram negative organisms
on initial gram stain did not initially receive gram negative
antibiotic coverage [16]. The Advisory Committee on Peritonitis
Management of the International Society of Peritoneal Dialysis
recommends to interpret gram stains as preliminary [17, 18], but
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did not suggest ignoring the gram stain findings. The outcomes
reported here could in part be explained by a delay in the
institution of appropriate antibiotic therapy. However, the nature
of the data collection does not allow detailed mechanistic hypoth-
eses to be addressed. The transmural migration of bacteria and
minute diverticular perforations have been suggested as possible
mechanisms in the development of gram negative peritonitis [5,
14]. Touch contamination and catheter related infections are
suggested causes for a large portion of gram positive peritonitis
episodes [5, 14]. If these are the predominant mechanisms, then
the incidence of gram negative peritonitis would be expected to
increase in the elderly and possibly in diabetics. In agreement with
the data of Holley et al [19], the Network 9 demographic data do
not reveal such an increase. Lastly, preliminary experiments in an
animal model suggest that E. coli peritonitis causes a worse
intraperitoneal reaction than does S. aureus [20].
Patients with a NPGN peritonitis episode have more severe
clinical symptoms and worse outcomes, even in the absence of
coincidental STIs, consistent with the observations of Tranaeus et
al [11]. This suggests that some other factors inherent to gram
negative organisms are responsible. Other possibilities to explain
the poor outcomes in the NPGN group include subclinical STIs
and the possibility of undiagnosed bowel disease. Significant
bowel disease or bowel perforation in peritoneal dialysis patients
have been reported to result in a polymicrobial peritonitis [5,
12—14, 21, 22]. Polymicrobial peritonitis was specifically excluded
from this analysis to diminish the probability that the source of the
bacterium was a bowel leak. Nonetheless, there was a suggestion
(P = 0.06) of an increase in the incidence of bowel perforations in
the NPGN group compared to the gram positive group. Despite
the unfavorable outcomes described in this report for NPGN
peritonitis and the higher likelihood of bowel disease in the
NPGN group, it should be noted that Kiernan et al [12] and
Holley et al [13] have suggested that even in polymicrobial
peritonitis, an aggressive search for bowel pathology may not
always be warranted.
S. aureus peritonitis predisposed patients to catheter removal
and transfer to hemodialysis when compared to infection with
other gram positive organisms or to CNS. The better outcomes of
S. epidermidis peritonitis when compared to other forms of
peritonitis have been noted before [7—9, 11]. Increased catheter
loss was still evident with S. aureus peritonitis even in the absence
of a STI. However, there were no differences in outcomes in the
S. aureus and CNS when a soft tissue infection was present. This
supports previous observations that a soft tissue infection plays a
pivotal role in the outcome of an episode of any type of staphy-
lococcal peritonitis [10, 23, 24].
In the present subset of patients with their first infection, those
whose first infection was caused by a gram positive organism were
more likely than those whose first infection was caused by a
NPGN to have further episodes of peritonitis in 1991. Impaired
opsonic activity is related to an increased incidence of gram
positive peritonitis [25]. Thus, gram positive peritonitis may be a
marker of susceptibility to peritonitis. These Network 9 Study
data are consistent with this as well as the observations of Golper
and Hartstein [26], who noted that patients with staphylococcal
peritonitis were more likely to have subsequent infections by any
organisms. Alternatively, patients with NPGN infections are more
likely to terminate peritoneal dialysis, thus not having subsequent
peritonitis.
The present data suggest that the outcome of non-pseudomonal
gram negative peritonitis is significantly worse than the outcome
of gram positive peritonitis with or without a concomitant STI.
Piraino and her associates [10, 24] have described the dismal
prognosis of peritonitis complicated by a coincidental STI. The
present data extend this concern in that a soft tissue infection is
associated with a lower rate of resolution, a higher rate of catheter
removal, and a higher rate of transfer to hemodialysis in both the
non-pseudomonal gram negative and gram positive groups.
Peritonitis caused by a single non-pseudomonal gram negative
organism appears to be a more serious infection than was
previously thought. While with NPGN infections there was a
statistically significant increase in the frequency of fever, nausea!
vomiting, and abdominal pain, this observation may not be
clinically useful. NPGN infections led to more prolonged antibi-
otics and worse outcomes. Undetected bowel leaks or STIs may
have been present. This warrants further study. In addition, the
poor outcomes even with more protracted antibiotic therapy
raises a concern as to the appropriate duration and intensity of
management of these infections. This concern may be raised
specifically regarding the practice within Network 9 (discussed in
[13]) or for formal recommendations. The Advisory Committee
on Peritonitis Management of the International Society of Pen-
toneal Dialysis recommends a 14-day antibiotic course for NPGN
(referred to as non-Xanthomonas) peritonitis and a 21-day course
for 5, aureus peritonitis [17]. While a longer duration of antibiotic
therapy may not improve outcomes, it seems reasonable to
reassess the NPGN recommendation in light of the present
findings.
These data lend strong support to the notion that the natural
history of apparently appropriately treated peritonitis differs by
the type of causative pathogen. All peritonitis episodes are not
equivalent in terms of outcomes. In light of the clearly different
outcomes of peritonitis caused by different pathogens, the infor-
mation transmitted by an infection rate is of limited value. The
concept of the "peritonitis infection rate" must be used selectively
and cautiously for certain comparisons. For example, from the
data presented in this report, a single episode of NPGN peritonitis
may lead to more prolonged illness than an episode of S.
epiderinidis peritonitis, and this may affect nutritional parameters
differently. Yet only one episode occurred in each case and
assuming equal time at risk, the "rate" was the same. One episode
of GNPN peritonitis will more likely lead to termination of
peritoneal dialysis than an episode caused by a gram positive
pathogen. The influence of "peritonitis rate," rather than caus-
ative pathogen, on mortality is especially suspect [27]. Thus, the
concept of "peritonitis rate" is only meaningful when specific
organisms are considered. Additional variables, such as duration
of cloudy fluid, anorexia, and transport abnormalities, etc., must
somehow be utilized to compare the ultimate consequences of
peritonitis. The peritoneal dialysis community needs to address
this issue, particularly in the present regulatory and competitive
(and thus comparative) environment.
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